Skip to content

Clinical trials

Dementia trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Not applicable Clear all

1,214 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20022
20031
20042
20058
200610
200712
200812
200913
201017
201121
201225
201328
201442
201538
201654
201754
201869
201973
202064
2021111
2022112
2023118
2024109
2025112
202689

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed696
Unknown status158
Recruiting157
Not yet recruiting79
Active, not recruiting49
Terminated28
Withdrawn24
Enrolling by invitation19
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Hong Kong Polytechnic University28
Indiana University19
University of Washington19
Johns Hopkins University18
VA Office of Research and Development18
Emory University17
The University of Hong Kong15
University of California, San Francisco15
University of Minnesota12
Chang Gung Memorial Hospital11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia1,214
Alzheimer Disease398
Cognitive Dysfunction304
Dementia, Vascular45
Anxiety Disorders41
Lymphoma, Follicular40
Memory Disorders40
Neurocognitive Disorders38
Lewy Body Disease37
Stroke33

Trials

Showing 51 to 75 of 1,214. Each trial links to its page on Pharma Observatory.

1,114 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.